Digital Health Views & Analysis

Views & Analysis

Considerations for Mobile Health Technology Developers: Part...

In Part 1 of this series, general wellness devices and mobile medical applications (MMAs) will be considered. Part 2 of this series will be devoted to clinical decision support (C

Views & Analysis

The NIH on accelerating research using diverse biomedical da...

Martin Mendoza, PhD, director of health equity and health science policy for the All of Us Research Program at the National Institutes of Health (NIH), tells pharmaphorum about the

Views & Analysis

AI diagnostics tools and oncology: predicting patient outcom...

AI French-American biotech start-up Owkin recently published new research in

Views & Analysis

As Apple rolls out medication tracking to all iPhones, pharm...

Imagine visiting your doctor’s office. Instead of swiping a co-pay card and filling out a paper form by hand, the receptionist says, “Please bring your phone closer.

Digital

Artificial intelligence in medicine

Thanks to constant advances in technology and science, artificial intelligence (AI) is rapidly becoming an integral part of modern healthcare.

Digital

Close up of lab assistant in uniform, with mask and rubber gloves holding test tube with blood sample while sitting on chair and typing on laptop. Selective focus on test tubes.

The future of AI drug discovery & development in immunology ...

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares.

Considerations for Mobile Health Technology Developers: Part...

The NIH on accelerating research using diverse biomedical da...

AI diagnostics tools and oncology: predicting patient outcom...

As Apple rolls out medication tracking to all iPhones, pharm...

Artificial intelligence in medicine

The future of AI drug discovery & development in immunology ...

Merck rare tumour drug Ezmekly backed for NHS use

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks